Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.63 SEK | -0.73% | +1.24% | -36.82% |
Apr. 13 | Certain B Shares of Biovica International AB are subject to a Lock-Up Agreement Ending on 13-APR-2024. | CI |
Apr. 12 | Biovica International AB Announces Divitum® Tka in Observational Trial | CI |
Sales 2024 * | 10M 921K | Sales 2025 * | 116M 10.68M | Capitalization | 138M 12.71M |
---|---|---|---|---|---|
Net income 2024 * | -115M -10.59M | Net income 2025 * | -60M -5.53M | EV / Sales 2024 * | 6.45 x |
Net cash position 2024 * | 73.52M 6.77M | Net cash position 2025 * | 45.95M 4.23M | EV / Sales 2025 * | 0.79 x |
P/E ratio 2024 * |
-0.22
x | P/E ratio 2025 * |
-0.57
x | Employees | 37 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.54% |
Latest transcript on Biovica International AB
1 day | -1.83% | ||
1 week | +0.12% | ||
Current month | +1.13% | ||
1 month | -32.27% | ||
3 months | -34.20% | ||
6 months | -36.54% | ||
Current year | -37.52% |
Managers | Title | Age | Since |
---|---|---|---|
Anders Rylander
CEO | Chief Executive Officer | 54 | 09-12-31 |
Anders Morén
DFI | Director of Finance/CFO | 59 | 22-12-31 |
Hanna Ritzen
CTO | Chief Tech/Sci/R&D Officer | 45 | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 64 | 19-03-19 | |
Annika Berg
BRD | Director/Board Member | 61 | 19-12-31 |
Maria Holmlund
BRD | Director/Board Member | 68 | 15-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 1.63 | -0.73% | 58 744 |
24-05-08 | 1.642 | -3.41% | 98,738 |
24-05-07 | 1.7 | +3.03% | 163,567 |
24-05-06 | 1.65 | +2.48% | 293,321 |
24-05-03 | 1.61 | +0.37% | 88,205 |
Delayed Quote Nasdaq Stockholm, May 10, 2024 at 04:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.52% | 12.7M | |
-26.80% | 9.96B | |
+65.44% | 3.76B | |
-28.13% | 2.37B | |
-10.06% | 2.27B | |
-25.01% | 1.58B | |
+50.53% | 1.31B | |
-2.84% | 750M | |
-7.83% | 575M | |
-27.35% | 525M |
- Stock Market
- Equities
- BIOVIC B Stock